Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2013 | |
| Sales | 24 | 18 | 0 | 0 | 2,547,300 |
| Cost of Goods | N/A | N/A | N/A | N/A | 1,067,900 |
| Gross Profit | 24 | 18 | N/A | N/A | 1,479,400 |
| Operating Expenses | 132,784 | 75,172 | 45,741 | 0 | 863,200 |
| Operating Income | -132,760 | -75,154 | -45,741 | N/A | 617,100 |
| Interest Expense | 0 | 0 | 0 | 0 | 91,600 |
| Other Income | -61,832 | -3,172 | -70,997 | 0 | -48,100 |
| Pre-tax Income | -194,592 | -78,326 | -116,738 | 0 | 477,400 |
| Income Tax | N/A | N/A | N/A | N/A | 111,900 |
| Net Income Continuous | -194,592 | -78,326 | -116,738 | N/A | 365,500 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -3,000 |
| Net Income | $-194,592 | $-78,326 | $-116,738 | $N/A | $362,500 |
| EPS Basic Total Ops | -4.19 | -14.05 | -40.54 | N/A | 2.24 |
| EPS Basic Continuous Ops | -4.16 | -12.09 | -40.34 | N/A | 2.26 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.02 |
| EPS Diluted Total Ops | -4.19 | -14.05 | -40.54 | N/A | 2.22 |
| EPS Diluted Continuous Ops | -4.16 | -12.09 | -40.34 | N/A | 2.24 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.02 |
| EPS Diluted Before Non-Recurring Items | -2.83 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-127,907 | $-72,571 | $-45,091 | $N/A | $738,100 |